2010
DOI: 10.1248/cpb.58.154
|View full text |Cite
|
Sign up to set email alerts
|

Micronization of Magnolia Bark Extract with Enhanced Dissolution Behavior by Rapid Expansion of Supercritical Solution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 17 publications
0
6
0
Order By: Relevance
“…Compared with the above inhibitors, magnolol has the advantages of abundant sources and easy preparation 26 , 27 . The high hydrophobicity and low solubility of magnolol may be the major obstacles to its bioavailability and clinical efficacy 28 , 29 . However, we revealed that the concentrations required to restore antimicrobial activity could be achieved in bacteria.…”
Section: Discussionmentioning
confidence: 99%
“…Compared with the above inhibitors, magnolol has the advantages of abundant sources and easy preparation 26 , 27 . The high hydrophobicity and low solubility of magnolol may be the major obstacles to its bioavailability and clinical efficacy 28 , 29 . However, we revealed that the concentrations required to restore antimicrobial activity could be achieved in bacteria.…”
Section: Discussionmentioning
confidence: 99%
“…However, many Chinese medicinal material extracts have poor solubility Molecular Pharmaceutics ARTICLE or slow dissolution rate, which may reduce tissue absorption and therapeutic potency upon administration. 27 With these therapeutic inadequacies, many efforts have been made to design new drug carrier systems that are able to improve the drug's solubility and stability in vivo, while retaining its therapeutic efficacy. To increase its solubility and bioavailability, attempts have been made through encapsulation using liposomes 28 and cyclodextrin.…”
Section: ' Introductionmentioning
confidence: 99%
“…To increase its solubility and bioavailability, attempts have been made through encapsulation using liposomes 28 and cyclodextrin. 27 Traditional liposomal drug carriers are limited by low drug encapsulation efficiency, poor storage stability, rapid clearance from the bloodstream, nonspecific uptake by the mononuclear phagocytic system, poor control over release of the drug from the liposome and rapid drug loss profiles in vivo. 29,30 Thus, colloidal drug carriers based on biodegradable polymers have received great attention recently for local release of drug toward the arterial wall.…”
Section: ' Introductionmentioning
confidence: 99%
See 2 more Smart Citations